The N.I.H. and Moderna are examining whether doses of Moderna’s coronavirus vaccine can be halved to double the supply, while scientists look for other ways to extend availability.
from NYT > Top Stories https://ift.tt/35bEX5S
https://ift.tt/eA8V8J
from NYT > Top Stories https://ift.tt/35bEX5S
https://ift.tt/eA8V8J